
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $739.6K | $12.9M | $15.9M | $17.5M | $14M | |
Revenue Growth (YoY) | -90.84% | 1637.77% | 23.98% | 9.75% | -19.97% | |
Cost of Revenues | $237.7K | $3M | $2.9M | $2.9M | $5.9M | |
Gross Profit | $501.9K | $9.8M | $13.1M | $14.6M | $8.1M | |
Gross Profit Margin | 67.86% | 76.48% | 82.06% | 83.49% | 58% | |
R&D Expenses | $32.2M | $20.5M | $19.4M | $43.2M | $47.8M | |
Selling, General & Admin | $27.4M | $23.1M | $32.4M | $44.7M | $81.6M | |
Other Inc / (Exp) | -- | -$53K | -$997K | -$2.3M | -$4.3M | |
Operating Expenses | $59.6M | $43.6M | $51.8M | $88M | $129.4M | |
Operating Income | -$59.1M | -$33.8M | -$38.8M | -$73.4M | -$121.3M | |
Net Interest Expenses | $673.6K | $729K | $1.2M | $2.8M | $4.8M | |
EBT. Incl. Unusual Items | -$59.8M | -$34.6M | -$41M | -$78.5M | -$130.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$59.8M | -$34.6M | -$41M | -$78.5M | -$130.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$59.8M | -$34.6M | -$41M | -$78.5M | -$130.4M | |
Basic EPS (Cont. Ops) | -$1.76 | -$0.70 | -$0.67 | -$1.21 | -$1.66 | |
Diluted EPS (Cont. Ops) | -$1.76 | -$0.70 | -$0.67 | -$1.21 | -$1.66 | |
Weighted Average Basic Share | $33.9M | $49.7M | $61M | $65M | $78.7M | |
Weighted Average Diluted Share | $33.9M | $49.7M | $61M | $65M | $78.7M | |
EBITDA | -$55.8M | -$28.2M | -$35M | -$70.1M | -$115.7M | |
EBIT | -$58.9M | -$33.8M | -$38.7M | -$72.2M | -$117.9M | |
Revenue (Reported) | $739.6K | $12.9M | $15.9M | $17.5M | $14M | |
Operating Income (Reported) | -$59.1M | -$33.8M | -$38.8M | -$73.4M | -$121.3M | |
Operating Income (Adjusted) | -$58.9M | -$33.8M | -$38.7M | -$72.2M | -$117.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.1M | $3.5M | $4.5M | $3M | $3.1M | |
Revenue Growth (YoY) | -- | 13.23% | 28.67% | -33.85% | 4.98% | |
Cost of Revenues | $694K | $694K | $654K | $1.5M | $1.5M | |
Gross Profit | $2.4M | $2.8M | $3.8M | $1.5M | $1.6M | |
Gross Profit Margin | 77.5% | 80.13% | 85.44% | 50.64% | 51.38% | |
R&D Expenses | $6.1M | $4.7M | $5.3M | $10.1M | $7M | |
Selling, General & Admin | $5.3M | $12.5M | $7.8M | $20.2M | $30.1M | |
Other Inc / (Exp) | -$53K | -$997K | -$2.3M | -- | -- | |
Operating Expenses | $11.4M | $17.3M | $13.1M | $30.3M | $37M | |
Operating Income | -$9M | -$14.5M | -$9.2M | -$28.8M | -$35.4M | |
Net Interest Expenses | $129K | $474K | $202K | $1.3M | $2.9M | |
EBT. Incl. Unusual Items | -$9.2M | -$15.9M | -$11.7M | -$30.1M | -$38.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$9.2M | -$15.9M | -$11.7M | -$30.1M | -$38.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$9.2M | -$15.9M | -$11.7M | -$30.1M | -$38.4M | |
Basic EPS (Cont. Ops) | -$0.21 | -$0.30 | -$0.18 | -$0.40 | -$0.45 | |
Diluted EPS (Cont. Ops) | -$0.21 | -$0.30 | -$0.18 | -$0.40 | -$0.45 | |
Weighted Average Basic Share | $43.4M | $52.5M | $64.7M | $75.4M | $85.2M | |
Weighted Average Diluted Share | $43.4M | $52.5M | $64.7M | $75.4M | $85.2M | |
EBITDA | -$7.4M | -$14.5M | -$10.1M | -$26.4M | -$33.2M | |
EBIT | -$9M | -$15.5M | -$10.6M | -$26.9M | -$33.7M | |
Revenue (Reported) | $3.1M | $3.5M | $4.5M | $3M | $3.1M | |
Operating Income (Reported) | -$9M | -$14.5M | -$9.2M | -$28.8M | -$35.4M | |
Operating Income (Adjusted) | -$9M | -$15.5M | -$10.6M | -$26.9M | -$33.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $13.3M | $16.9M | $16M | $14.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $3M | $2.8M | $3.7M | $5.9M | |
Gross Profit | $2.9M | $10.2M | $14.1M | $12.3M | $8.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $27.5M | $19.2M | $20M | $48M | $44.8M | |
Selling, General & Admin | $28.9M | $30.3M | $27.7M | $57.2M | $91.4M | |
Other Inc / (Exp) | -$53K | -$997K | -$2.3M | -- | $7.2M | |
Operating Expenses | $56.3M | $49.5M | $47.6M | $105.2M | $136.1M | |
Operating Income | -$53.4M | -$39.3M | -$33.5M | -$93M | -$127.9M | |
Net Interest Expenses | $657.3K | $1.1M | $976K | $3.9M | $7.1M | |
EBT. Incl. Unusual Items | -$54.2M | -$41.3M | -$36.8M | -$96.8M | -$127.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$54.2M | -$41.3M | -$36.8M | -$96.8M | -$138.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$54.2M | -$41.3M | -$36.8M | -$96.8M | -$127.8M | |
Basic EPS (Cont. Ops) | -$1.48 | -$0.80 | -$0.56 | -$1.42 | -$1.58 | |
Diluted EPS (Cont. Ops) | -$1.48 | -$0.80 | -$0.56 | -$1.42 | -$1.58 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$49.4M | -$35.3M | -$30.6M | -$86.4M | -$111M | |
EBIT | -$53.4M | -$40.2M | -$33.8M | -$88.5M | -$113.2M | |
Revenue (Reported) | -- | $13.3M | $16.9M | $16M | $14.1M | |
Operating Income (Reported) | -$53.4M | -$39.3M | -$33.5M | -$93M | -$127.9M | |
Operating Income (Adjusted) | -$53.4M | -$40.2M | -$33.8M | -$88.5M | -$113.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.1M | $3.5M | $4.5M | $3M | $3.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $694K | $694K | $654K | $1.5M | $1.5M | |
Gross Profit | $2.4M | $2.8M | $3.8M | $1.5M | $1.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $6.1M | $4.7M | $5.3M | $10.1M | $7M | |
Selling, General & Admin | $5.3M | $12.5M | $7.8M | $20.2M | $30.1M | |
Other Inc / (Exp) | -$53K | -$997K | -$2.3M | -- | -- | |
Operating Expenses | $11.4M | $17.3M | $13.1M | $30.3M | $37M | |
Operating Income | -$9M | -$14.5M | -$9.2M | -$28.8M | -$35.4M | |
Net Interest Expenses | $129K | $474K | $202K | $1.3M | $2.9M | |
EBT. Incl. Unusual Items | -$9.2M | -$15.9M | -$11.7M | -$30.1M | -$38.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$9.2M | -$15.9M | -$11.7M | -$30.1M | -$38.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$9.2M | -$15.9M | -$11.7M | -$30.1M | -$38.4M | |
Basic EPS (Cont. Ops) | -$0.21 | -$0.30 | -$0.18 | -$0.40 | -$0.45 | |
Diluted EPS (Cont. Ops) | -$0.21 | -$0.30 | -$0.18 | -$0.40 | -$0.45 | |
Weighted Average Basic Share | $43.4M | $52.5M | $64.7M | $75.4M | $85.2M | |
Weighted Average Diluted Share | $43.4M | $52.5M | $64.7M | $75.4M | $85.2M | |
EBITDA | -$7.4M | -$14.5M | -$10.1M | -$26.4M | -$33.2M | |
EBIT | -$9M | -$15.5M | -$10.6M | -$26.9M | -$33.7M | |
Revenue (Reported) | $3.1M | $3.5M | $4.5M | $3M | $3.1M | |
Operating Income (Reported) | -$9M | -$14.5M | -$9.2M | -$28.8M | -$35.4M | |
Operating Income (Adjusted) | -$9M | -$15.5M | -$10.6M | -$26.9M | -$33.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $65.3M | $57.5M | $93.3M | $83.7M | $176.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $3M | $5M | $4.1M | $2.7M | |
Inventory | -- | -- | -- | -- | $241K | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $752.5K | $792K | $1.5M | $2.2M | $5.7M | |
Total Current Assets | $66.1M | $61.3M | $99.8M | $89.9M | $185.1M | |
Property Plant And Equipment | $9.5M | $7.4M | $6.3M | $6.2M | $12.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | |
Other Intangibles | $5.5M | $4.4M | $3.7M | $3.4M | $3.2M | |
Other Long-Term Assets | $390K | $6.6M | $6.9M | $7M | $18.4M | |
Total Assets | $99.5M | $93.7M | $129.2M | $118.3M | $230.3M | |
Accounts Payable | $3.7M | $1.1M | $2.2M | $1.4M | $4.7M | |
Accrued Expenses | $1.4M | $2M | $2.7M | $4.9M | $8.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $2.6M | $18M | |
Current Portion Of Capital Lease Obligations | $1.6M | $1.1M | $1.1M | $1.1M | $417K | |
Other Current Liabilities | $1.8M | -- | -- | -- | -- | |
Total Current Liabilities | $11.7M | $7.3M | $8.8M | $18.6M | $41.8M | |
Long-Term Debt | $10.3M | $10.4M | $19.9M | $43.4M | $97.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $28.4M | $28.5M | $38.8M | $71M | $153M | |
Common Stock | $43.3K | $52K | $64K | $69K | $85K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $71.1M | $65.3M | $90.4M | $47.3M | $77.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $71.1M | $65.3M | $90.4M | $47.3M | $77.3M | |
Total Liabilities and Equity | $99.5M | $93.7M | $129.2M | $118.3M | $230.3M | |
Cash and Short Terms | $65.3M | $57.5M | $93.3M | $83.7M | $176.5M | |
Total Debt | $10.3M | $10.4M | $19.9M | $46M | $115.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $53.6M | $57.8M | $94.4M | $157.9M | $169.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $627.6K | $3.3M | $4.1M | $2.6M | $1.2M | |
Inventory | -- | -- | -- | $3.5M | $1.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $814.1K | $874K | $1.1M | $4M | $4.9M | |
Total Current Assets | $55.1M | $62M | $99.7M | $167.9M | $177.2M | |
Property Plant And Equipment | $8.9M | $7M | $6.4M | $7.2M | $12.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | |
Other Intangibles | $5.2M | $4.2M | $3.6M | $3.4M | $3.1M | |
Other Long-Term Assets | $350.9K | $307K | $6.9M | $6.9M | $23.4M | |
Total Assets | $88.5M | $93.5M | $128.9M | $197.1M | $227.4M | |
Accounts Payable | $3M | $1.7M | $841K | $2.5M | $8.7M | |
Accrued Expenses | $2.4M | $4.3M | $1.9M | $9.4M | $7.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $37.6M | |
Current Portion Of Capital Lease Obligations | $1M | $1.1M | $1M | $1.2M | $377K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $7.9M | $8M | $6.8M | $21.9M | $60.5M | |
Long-Term Debt | $10.2M | $19.5M | -- | -- | $103.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $25.5M | $38.1M | $47.3M | $110.9M | $177.7M | |
Common Stock | $43.4K | $53K | $65K | $76K | $85K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $62.9M | $55.4M | $81.6M | $86.3M | $49.7M | |
Total Liabilities and Equity | $88.5M | $93.5M | $128.9M | $197.1M | $227.4M | |
Cash and Short Terms | $53.6M | $57.8M | $94.4M | $157.9M | $169.8M | |
Total Debt | $10.2M | $19.5M | -- | -- | $140.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$59.8M | -$34.6M | -$41M | -$78.5M | -$130.4M | |
Depreciation & Amoritzation | $3.1M | $5.6M | $3.6M | $2.2M | $2.2M | |
Stock-Based Compensation | $4M | $6.7M | $9.3M | $10.1M | $18.8M | |
Change in Accounts Receivable | -- | -$3M | -$2M | $956K | $1.3M | |
Change in Inventories | -- | -- | -- | -- | -$241K | |
Cash From Operations | -$54.1M | -$34M | -$28.6M | -$41.6M | -$93.4M | |
Capital Expenditures | $752.1K | $107K | $592K | $11.3M | $8.4M | |
Cash Acquisitions | $1M | -- | -- | -- | -- | |
Cash From Investing | $247.9K | -$107K | -$587K | -$11.3M | -$8.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $10.4M | $19.8M | $41.7M | $57.5M | |
Long-Term Debt Repaid | -$6.8M | -$10.8M | -$10.8M | -$24M | -$5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.1M | $5M | $451K | $113K | $593K | |
Cash From Financing | $63.4M | $26.3M | $65M | $43.2M | $194.7M | |
Beginning Cash (CF) | $55.8M | $65.3M | $57.5M | $93.3M | $83.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $9.5M | -$7.8M | $35.8M | -$9.6M | $92.8M | |
Ending Cash (CF) | $65.3M | $57.5M | $93.3M | $83.7M | $176.5M | |
Levered Free Cash Flow | -$54.9M | -$34.1M | -$29.2M | -$52.9M | -$101.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$9.2M | -$15.9M | -$11.7M | -$30.1M | -$38.4M | |
Depreciation & Amoritzation | $1.6M | $947K | $569K | $489K | $451K | |
Stock-Based Compensation | $745K | $4.2M | $2.6M | $4.5M | $7.4M | |
Change in Accounts Receivable | -$628K | -$297K | $886K | $1.5M | $1.5M | |
Change in Inventories | -- | -- | -- | -$3.5M | -$1.1M | |
Cash From Operations | -$12.4M | -$9.8M | -$8.5M | -$24.9M | -$30.7M | |
Capital Expenditures | $52K | -- | $366K | $624K | $330K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$52K | -- | -$364K | -$624K | -$330K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $10.4M | $19.8M | $31.8M | $25M | $25M | |
Long-Term Debt Repaid | -$10.6M | -$10.6M | -$22.3M | -$680K | -$2.2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $927K | $276K | $17K | $3K | $235K | |
Cash From Financing | $759K | $10.1M | $10M | $99.7M | $24.3M | |
Beginning Cash (CF) | $65.3M | $57.5M | $93.3M | $83.7M | $176.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$11.7M | $300K | $1.1M | $74.2M | -$6.7M | |
Ending Cash (CF) | $53.6M | $57.8M | $94.4M | $157.9M | $169.8M | |
Levered Free Cash Flow | -$12.4M | -$9.8M | -$8.8M | -$25.5M | -$31M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$54.2M | -$41.3M | -$36.8M | -$96.8M | -$138.7M | |
Depreciation & Amoritzation | $4M | $5M | $3.3M | $2.1M | $2.2M | |
Stock-Based Compensation | $3.8M | $10.2M | $7.7M | $12.1M | $21.7M | |
Change in Accounts Receivable | -$628K | -$2.7M | -$844K | $1.6M | $1.3M | |
Change in Inventories | -- | -- | -- | -$3.5M | $2.2M | |
Cash From Operations | -$52.1M | -$31.4M | -$27.3M | -$58M | -$99.2M | |
Capital Expenditures | $621.9K | $55K | $958K | $11.5M | $8.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $378.1K | -$55K | -$951K | -$11.5M | -$8.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $10.4M | $19.8M | $31.8M | $34.9M | $57.5M | |
Long-Term Debt Repaid | -$15.6M | -$10.8M | -$22.5M | -$2.4M | -$6.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$130.7K | $4.3M | $192K | $99K | $825K | |
Cash From Financing | $65.2M | $35.6M | $64.8M | $133M | $119.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $13.5M | $4.2M | $36.6M | $63.4M | $11.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$52.7M | -$31.5M | -$28.2M | -$69.5M | -$107.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$9.2M | -$15.9M | -$11.7M | -$30.1M | -$38.4M | |
Depreciation & Amoritzation | $1.6M | $947K | $569K | $489K | $451K | |
Stock-Based Compensation | $745K | $4.2M | $2.6M | $4.5M | $7.4M | |
Change in Accounts Receivable | -$628K | -$297K | $886K | $1.5M | $1.5M | |
Change in Inventories | -- | -- | -- | -$3.5M | -$1.1M | |
Cash From Operations | -$12.4M | -$9.8M | -$8.5M | -$24.9M | -$30.7M | |
Capital Expenditures | $52K | -- | $366K | $624K | $330K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$52K | -- | -$364K | -$624K | -$330K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $10.4M | $19.8M | $31.8M | $25M | $25M | |
Long-Term Debt Repaid | -$10.6M | -$10.6M | -$22.3M | -$680K | -$2.2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $927K | $276K | $17K | $3K | $235K | |
Cash From Financing | $759K | $10.1M | $10M | $99.7M | $24.3M | |
Beginning Cash (CF) | $65.3M | $57.5M | $93.3M | $83.7M | $176.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$11.7M | $300K | $1.1M | $74.2M | -$6.7M | |
Ending Cash (CF) | $53.6M | $57.8M | $94.4M | $157.9M | $169.8M | |
Levered Free Cash Flow | -$12.4M | -$9.8M | -$8.8M | -$25.5M | -$31M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.